ALTIOR TRAUMA ANNOUNCES FDA 510(K) CLEARANCE FOR THE ARTEMIS PROXIMAL FEMORAL NAIL SYSTEM (press release)
A FOURTH-GENERATION HIP FRACTURE NAIL MANUFACTURED USING A REVOLUTIONARY PROCESS
Altior Trauma, a GLW, Inc. company, (“Altior Trauma”) announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Artemis Proximal Femoral Nail System (the “Artemis System”), a hip fracture nail. The Artemis System offers an advancement in hip fracture treatment that combines the strength of titanium with a unique blend of Solvay Zeniva® carbon fiber reinforced polyetheretherketone (“CF PEEK”), a radiolucent polymer. This proprietary process of combining materials allows for greater skeletal visualization and has the potential for the promotion of fracture healing.
“The Artemis System is truly a global product platform that delivers modern innovation. I am incredibly proud of our engineers and what they have accomplished in order to deliver a next generation hip fracture nail utilizing a patent pending advanced manufacturing process that significantly reduces costs,” said Vadim Gurevich, CEO of Altior Trauma. “The launch of Artemis, our f...
